Cancer Drugs News

Natco Generic Lenalidomide capsules used for treatment of multiple myeloma.

Natco Pharma and its US accomplice Allergan have settled a pending suit with biopharmaceutical firm Celgene in regards to nonspecific Lenalidomide cases utilized for treatment of different myeloma. The deal provides Natco with the certainty of a generic Revlimid launch in the US as well as a billion-dollar windfall “Celgene has consented to furnish Natco with a permit to Celgenes licenses required to make and offer a boundless amount of bland Lenalidomide in the United Read more…

By Team MedsDelta, ago
Cancer Drugs News

肺癌什么时期化疗最有效 , 北京市, 天津市,上海市

这意味着,基因突变的晚期肺癌患者可在被诊断初期就选用比化疗更有效、耐受性更好的靶向药物治疗方案。幸运的是,亚洲患者的基因突变发生率为30%~40%,高于欧洲的10% ~15%,越来越多的临床试验结果表明,发生基因突变的这类肿瘤对酪氨酸激酶按捺剂高度敏感。 非小细胞肺癌个体化治疗方案的确定,依靠于基因突变检测的结果。个体化治疗模式就是根据肺癌患者的基因结构信息,有针对性地选择并确定最适合患者的治疗方案。这就使我们越发熟悉到应当根据肺癌的分子类型进行靶向治疗。临床选择前提不同的患者,分子靶向治疗药物的疗效也不一样。如斯,靶向药物才能找到合适的靶点并充分施展疗效。 2009年7月1日,肺癌靶向药物吉非替尼(易瑞沙)在欧洲被批准可用于敏感人群一线治疗,这是全球肺癌个体化治疗的一个里程碑。 ” 中国癌症基金会控烟与肺癌防治工作部主任、中国抗癌协会科普工作部部长、首都医科大学肺癌诊疗中央主任支修益教授先容,肺癌患者尤其长短小细胞肺癌患者,确诊时有85%左右都是晚期或局部晚期。 肺癌个体化治疗策略的推广和临床应用是今年美国临床肿瘤学会年会ASCO和第十三届世界肺癌大会WCLC所倡导的肺癌治疗新理念。 “跟着临床医生经验的累积和大量临床试验的结果表明,肺癌是由多种发病机制所引起的,包括各种不同的生物途径。 ”支修益教授夸大道,“我相信,在肺癌防治领域,取得重大突破的可能性是有的,而且很大程度上取决于同临床紧密亲密相关的转化临床研究的进展。大多数晚期肺癌患者没有手术根治性治疗的机会,化放疗的临床效果也不理想,从而导致肺癌死亡率的居高不下。 北京市,天津市,上海市,重庆市,河北省,山西省,吉林省,黑龙江,江苏省,浙江省,安徽省,福建省,山东省,河南省,湖北省,四川省,陕西省,云南省,贵州省 QQ:3451266709 , Wechat:Medsdelta

By Team MedsDelta, ago
Cancer Drugs News

Lenvatinib is expected to become a new choice for the treatment of advanced liver cancer

Lenvatinib (levalinib) is a tiny molecular targeted medicine targeting VEGFR2/VEGFR3, PDGFR, FGFR. Currently, Lenvatinib (levalatinib) has been approved for the treating advanced thyroid cancer and renal cancer, and trial offers for the treatment of solid tumors such as non-small cell lung cancers, glioma, and endometrial tumor are ongoing Recently, at the World Hepatitis Convention, Eisai announced that the updated Levastatin challenged the first-line phase III studies of Nexavar for treating advanced liver cancer. With this Read more…

By Team MedsDelta, ago
Cancer Drugs News

Precaution before Total Knee Replacement Surgery

What Precautions can be taken Before Total Knee Replacement Surgery? The eating habits of the people have been changed drastically. They don’t want to have home-cooked foods. Instead, fast food is quite in fashion. Most of the people especially females and children are more prone to have pizzas, burgers and other fried stuff. This tends to make people obese. The fat gets accumulated in the body and affects your muscles. Simultaneously, it weakens your immune Read more…

By Team MedsDelta, ago
Targeted Cancer Drugs From India

Colon cancer: Symptoms, treatment, and causes And Medicine : MedsDelta.Com

Get the certainties on colon disease (colorectal Cancer ) Medicine, side effects, stages, treatment, screening, causes, surgery, and survival. Take in the phases of colon malignancy and what to do about polyps.  Colon Cancer is a standout amongst the most widely recognized kinds of growth that influences the two guys and females after their age of 40. Essentially, it is a typical sort of danger where cells development increments inside your colon and rectum. At Read more…

By Team MedsDelta, ago
Cancer Drugs News

Prostate Cancer Drugs Its Survival Rate , Prostate Treatment Options

What Is Prostate Cancer ? Whats the Survival Rate ? Can This Kills ? Latest Prostate Cancer Treatment Medicine. Before profound making a plunge understanding prostate disease. There are a couple of certainties about Prostate Cancer with regards to India that you should think about – Anticipated instances of prostate Cancer the whole way across India for the periods 2010 – 2015 were evaluated as 26,120 and 28,079. The rate rates of this disease are Read more…

By Team MedsDelta, ago
Cancer Drugs News

New Targeted Medicine For Kindney Cancer

What is kidney Cancer? The kidneys are two bean-formed organs, every one about the span of a clench hand. Renal disease is where renal cells end up noticeably harmful (dangerous), lose their development issue, and shape tumors. They lay on the lower guts on the two sides of your spine. Most kidney growths are found before they spread to removed organs. Their primary occupation is to scrub your blood, expel squander and urinate. Medicine Approved Read more…

By Team MedsDelta, ago
Cancer Drugs News

LUNG CANCER – WARNING SIGNS AND SYMPTOMS YOU SHOULD NEVER IGNORE

There are two main types of lung cancer: non-small cell and small-cell. Learn about how these lung cancers are caused, your treatment options, and more MedsDelta Worldwide Supplier Of Lung Cancer Medicine Like Azd9291, iressa , Crizotinib Etc QQ:3451266709, Wechat:medsdelta , Get Medicine In China From MedsDelta. 有针对性的癌症药物中国 Lung Cancer is a standout amongst the most well-known and most forceful harmful tumors in people. Just in US, in 2010 there were 239,320 new instances of lung tumor and 161,250 passings Read more…

By Team MedsDelta, ago
Cancer Drugs News

Tafnat Tenofovir Alafenamide 25mg Tablets Launch In India

Tafnat Tablets generic version of Tenofovir Alafenamide Launch By Natco India Natco Pharma has launched a generic version of Tenofovir Alafenamide, a drug used for treating chronic Hepatitis B. The company in a communique to BSE, said that it’s one of the first entities to launch the generic version of the drug under its brand Tafnat. Natco is producing Tafnat under license from Medicines Patent Pool (MPP) and Gilead Sciences. The company has priced the medicine at Read more…

By Team MedsDelta, ago
Hepatitis Medicine India

Mylan Launches “HepBest”chronic hepatitis B treatment tablets in India

Hepbest : Generic Tenofovir Alafenamide tablets Launch By Mylan India The tablet has been launched in the strength of 25 mg, it added. Commenting on the development, Mylan India and Emerging Markets President Rakesh Bamzai said: “Mylan continues to be in the forefront of introducing new treatment regimens for the management of hepatitis in India.” Storage And Handling Of Hepbest HepBest tablets containing 25 mg of tenofovir alafenamide are yellow, round, film-coated, debossed with “GSI” on Read more…

By Team MedsDelta, ago
Cancer Drugs News

What Is Cirrhosis and Hepatitis C ?

What Is Cirrhosis and Hepatitis C ? An estimated 3.5 million people in the United States have a chronic hepatitis C infection. Yet most people infected with the hepatitis C virus (HCV) don’t even know they have it. Over the course of years, HCV infection can cause major damage to the liver. For every 100 people with chronic HCV infection, between 5 and 20 people will go on to develop cirrhosis. In fact, HCV infection Read more…

By Team MedsDelta, ago
Cancer Drugs News

鲁索利替尼片规格 , 骨髓癌 , Jakavi 20毫克片剂 ,癌症 癌症药物批发 ,香港,中国

鲁索利替尼片 【英文商品名】Jakavi 【英文药品名】Ruxolitinib 【中文药品名】鲁索利替尼片 【生产厂家名】瑞士诺华           QQ:3451266709 鲁索替尼(Jakafi)捷恪卫哪里有?鲁索替尼片(JAKAFI)目前已在美国、欧洲等地上市,但仍未在中国大陆上市,香港致泰药业代理供应瑞士诺华制药公司鲁索利替尼,香港致泰药业是经香港政府卫生署注册的药品批发商,超过30年香港药房运营经验,与全球各大制药厂建立起良好的合作关系,专注于全球新特药品进出口业务, 【鲁索利替尼片用法用量】 (1)对血小板计数大于200/μL患者,Jakavi的开始剂量是20 mg口服每天2次给药,而对血小板计数100/μL和200/μL间患者15 mg每天2次。 (2)起始用鲁索利替尼Jakavi治疗前进行完全血细胞计数。监视完全血细胞计数s 每2至4周直至剂量稳定化,,和然后当临床指示。对血小板计数减低调整剂量。 (3)根据反应增加剂量和因推荐至最大每天2次25 mg。如脾脏无减小或症状无改善6个月后终止。 【鲁索利替尼片不良反应】 最常见血液学不良反应(发生率 > 20%)是血小板计数减低和贫血。最常见非血液学不良反应(发生率 >10%) 是瘀斑, 眩晕和头痛。 【鲁索利替尼片注意事项】 (1)可能发生血小板计数减低,贫血和中性粒细胞减少。用减低剂量,或中断或输血处理。 (2)评估患者感染的体征和症状和及时开始适当治疗。开始用鲁索利替尼Jakavi治疗前严重感染应已解决。 【鲁索利替尼片规格】 5mg,15MG,20mg,56片/瓶 【鲁索利替尼片贮藏】 贮存在室温20°C至25°C;外出允许15°C和30°C间。 【鲁索利替尼片生产企业】瑞士诺华

By Team MedsDelta, ago
Cancer Drugs News

Velpatasvir Sofosbuvir Tablets ( Epclusa) : The Miracle Life Saver For Hepatitis C Genotype Patients

Hepatitis C infection (HCV) is a worldwide risk. Around, 200 million patients are tainted around the world. This is the most widely recognized blood-borne contamination in the US with various wellbeing suggestions. These are incorporated liver fibrosis, cirrhosis, and hepatocellular tumor. Customary HCV treatments which used to be with interferon brought about an exceptionally direct achievement rate. In the current investigates of the once-day by day mix tablet of sofosbuvir, a nonstructural (NS) 5B polymerase Read more…

By Team MedsDelta, ago
Targeted Cancer Drugs From India

寻找印度抗癌靶药点滴分享,希望帮到更多人

家属今年暑假常规体检,肺部有阴影,后来通过各种检查确诊肺癌中晚期,然后马上在医院动了微创手术,手术恢复良好,因为年纪大了,家人考虑到后期化疗对老人是身心折磨,通过基因检查,后期可以服用特罗凯。然后家人和我说能不能买到印度仿制药,因为价格会便宜很多。对于一个普通家庭来说,国内的抗癌药真是天价。在寻找购买药物的过程花费了我好长时间,问遍了能问的朋友,网上找了一些能购买的地方,不是价格太高,就是有些明显不可信(明明在国内,非说是在印度留学工作,一看朋友圈图片就是google搜的,完全不可信)。然后我通过朋友介绍,认识了几个印度人,还好本人在国外,周围有一些印度同事,朋友周围有一些印度同事。直接想法就是让印度人帮忙。其中一个正好在印度回国度假,然后我请他购买了几盒特罗凯,人民币1300,然后我另外给了一部分麻烦费用,到了这边再请人带到国内,非常感谢帮忙带过来的印度朋友,也非常感谢帮忙带回去的同学,同时也非常感谢周围的朋友帮忙,幸好时间来得及。同时,另外一个印度朋友后来介绍了一个印度供药商,价格便宜很多。可以直接邮寄到中国,方便很多,我怕东西有问题,所以也买了几盒,然后都到了国内以后,把药拿给医生专家看了,没有问题。 后来一个亲戚得知消息后,问我能不能帮忙问一种治疗肺纤维化的需要长期服用,他们已经花了10万人民币,然后我问了印度朋友,他暂时没有销售那种药物,但是帮我询问了其他药物供应商,后来终于买到了印度版的,价格比国内确实便宜很多。印度供药商可以提供各种抗癌药,易瑞沙,特罗凯,9291等,价格比较便宜,是一位有爱心,有责任,有信仰,值得信赖的供药商。有需要可以咨询,为了让更多的患者买到质量有保证,价格实惠的药品。希望能帮到一部分正在为寻药,买药的患者,患者家属。 以下是印度朋友的联系方式: 微信:qqdg2000(中英文服务),MedsDelta(英文服务) QQ : 2565482642(中英文服务),3451266709(英文服务) Mobile : +91-9971646666 (印度当地电话,英文服务) Website:https://www.medsdelta.com/(英文服务) 以下是印度朋友提供的一些常用的药品名单: names in chineese and english ————————————– Gefitinib/吉非替尼/易瑞沙/Iressa, Erlotinib/厄洛替尼/特罗凯/Tarceva, Afatinib/BIBW2992/阿法替尼/妥复克, Crizotinib/克唑替尼/赛可瑞/Xalkori; Imatinib/伊马替尼/格列卫/Glivec; Dasatinib/达沙替尼/施达赛/Sprycel; Sorafenib/索拉非尼/多吉美/Nexar; Sunitinib/舒尼替尼/索坦/Spunit; Abiraterone/阿比特龙; Regorafenib/Stivarga/瑞戈非尼; Lenalidomide/雷利度胺/来那度胺; Everolimus/依维莫司/Certican; Temozolomide/替莫唑胺; Lapatinib/拉帕替尼/泰克布/Tykerb; Pazopanib/帕唑帕尼/Votrient; Nilotinib/Tasigna/尼洛替尼/达希纳; Alphalan/Melphalan/马法兰; Letrozole/来曲唑/绯玛拉/弗隆/Femara; Arimidex/阿那曲唑/瑞宁得/; febuxostat/非布司他; Pirfenex/吡非尼酮;;HCV/ Harvoni/哈瓦尼/吉二代; Sofosbuvir/索菲布韦/Hepcinat; Daclatasvir/达卡他韦; AZD9291; /Oscimertinib ibrutinib/Imbruvica/依鲁替尼

By Team MedsDelta, ago
Cancer Drugs News

Lung Cancer : How To Cure & Prevent With Cancer

Lung tumor is the main source of malignancy passings in men, both in the United States , China, Hongkong, UK, Russia and around the world.• Cancer is among the most well-known reasons for death in male grown-ups. • The sound eating regimen can diminish the danger of building up certain disease. The other thing is qualities can assume a noteworthy part in tumor ailment. 3.  Once growth spread it is hard to treat .knowing early Read more…

By Team MedsDelta, ago
Cancer Drugs News

Vosevi for Hepatitis C approved by FDA : sofosbuvir and velpatasvir & voxilaprevir.

 Gilead’s Vosevi (sofosbuvir/velpatasvir/voxilaprevir) for re-treatment of grown-ups with ceaseless hepatitis C infection. More profound Insights Handling Disintermediation Through Enhanced Service Gilead Sciences, Inc. reported that the U.S. Sustenance and Drug Administration (FDA) has endorsed Vosevi (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg) tablets, a solitary tablet regimen for the re-treatment of perpetual hepatitis C infection (HCV) disease in grown-ups with genotype 1, 2, 3, 4, 5 or 6 already treated with a NS5A inhibitor-containing regimen, Read more…

By Team MedsDelta, ago
Cancer Drugs News

Cancer Treatment Hospitals Delhi , India

Top Cancer Treatment Hospitals in Delhi (India) About MedsDelta.com: We are Leading Supplier And Exporter of all Lifesaving pharmaceutical Such As Cancer, Hepatitis, Acne, Arthritis, HIV AIDS, Etc, Call us For any Cancer drugs +919971646666 or QQ:3451266709 ” A huge number of individuals are determined to have Cancer consistently in India and over the globe yet after a conclusion of growth genuine adventure starts as there are more than 200 sorts of tumor on the Read more…

By Team MedsDelta, ago
Cancer Drugs News

ZYDELIG® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia

Zydelig (Idelalisib) Chemotherapy Drug Information Individuals with specific sorts of leukemia and lymphoma that has returned after treatment now have another medication treatment to attempt. The U.S. Sustenance and Drug Administration (FDA) has endorsed idelalisib (Zydelig) for individuals with backslid perpetual lymphocytic leukemia (CLL), backslid follicular B-cell non-Hodgkin lymphoma, and backslid little lymphocytic lymphoma (another sort of non-Hodgkin lymphoma). Zydelig is a pill taken twice per day. It focuses on a protein found in the Read more…

By Team MedsDelta, ago
Cancer Drugs News

Takeda Pharma announces FDA Accelerated Approval of ALUNBRIG™ (brigatinib) for Lung Cancer

Takeda Announces Publication of ALUNBRIG™ (brigatinib) Pivotal Phase 2 ALTA Clinical Trial Data in Journal of Clinical Oncology Takeda Pharmaceutical Company Limited declared that ALUNBRIG™ (brigatinib) has gotten Accelerated Approval from the U.S. Sustenance and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-little cell lung disease (NSCLC) who have advanced on or are narrow minded to crizotinib. This sign is endorsed under Accelerated Approval in view of tumor Read more…

By Team MedsDelta, ago
Indian Generic Drugs

Scapho Injection : Secukinumab Novartis launches new drug for psoriasis treatment in India

There is a good news for patients in India suffering from psoriasis particularly plaque psoriasis. Novartis has announced launch of a new drug secukinumab in India with brand name Scapho Injection for the treatment of moderate-to-severe plaque psoriasis in Patients who are candidates for systemic therapy or phototherapy. Secukinumab Injection which is already approved in over 50 countries for the treatment of plaque psoriasis has been approved by the Drug Controller General of India (DCGI). Read more…

By Team MedsDelta, ago
Cancer Medicine

Lynparza Novartis olaparib Capsule , First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors

Astra Zeneca’s Lynparza olaparib slowed the progression of breast blight acquired in allotment by mutations in the BRCA gene, an affiliated action that causes up to 3% of all breast cancers. These cancers are decidedly harder to treat, and some women who analysis absolute for BRCA genes opt for bifold mastectomies in adjustment to lower their risk. In a abstraction of 302 women whose breast blight had spread, olaparib Lynparza Capsules bargain the accident of blight growing Read more…

By Team MedsDelta, ago
Cancer Medicine

Opdivo, Keytruda launches in India slated by End of Year

indian cancer sufferers may be set to acquire two of the sector’s main oncology tablets, msd’s keytruda and bristol-myers squibb’s opdivo, through the give up of this 12 months in step with the financial times. keytruda, which has constantly completed well in lung cancer and advanced cancer,changed into recently authorised the drug controller popular of india, in line with a top fitness ministry legitimate. opdivo, alternatively, recently acquired horrific news as it did not meet Read more…

By Team MedsDelta, ago
Cancer Medicine

Roche’s Alecensa Alectinib bests Pfizer’s Xalkori crizotinib lung cancer trial

Alecensa Alectinib Capsules Who is alectinib for? Alectinib is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant of crizotinib, a drug for ALK-positive NSCLC widely approved (e.g. in USA by FDA  and in Europe by EMA ) Roche has bestowed late-stage information showing that its Alecensa was superior to on progression-free survival in patients with a particular style of carcinoma. Read more…

By Team MedsDelta, ago
Cancer Medicine

Dr Reddy’s Labs receives US FDA marketing approval for generic Doxil ( doxorubicin liposomal)

 Dr Reddy’s Labs receives US FDA marketing approval for generic Doxil Dr Reddy’s Laboratories Ltd. has received approval from the US Food and Drug Administration (FDA) to launch doxorubicin hydrochloride liposome injection, a therapeutic equivalent generic version of Doxil (doxorubicin hydrochloride liposome injection), for intravenous use, in the United States market. The  US FDA approval is an outcome of extensive collaboration with the company’s partner, Natco Pharma Ltd., on R&D and manufacturing capabilities. “This approval Read more…

By Team MedsDelta, ago
Indian Generic Drugs

Bedaquiline : The roll out of a TuberCulosis curing miracle drug India

Treating drug resistant TB can take years and can cost 200 times as much as treating ordinary diseases. Approval for the drug Bedaquiline marks the first time in 40 years that FDA has approved the drug that attacks TB in different ways from current treatment. Discovered by scientists at Janssen, the pharmaceuticals unit of Johnson & Johnson, Monday saw the roll out of this ‘miracle drug’. Sunil Khaparde, Deputy Director General, Central TB division, Union Read more…

By Team MedsDelta, ago
Cancer Medicine

Natco Launches Pomalid Capsules Generic Pomalidomide Capsules in India

Blood Cancer Medicine  Pomalidomide Capsule By Natco Pharma India Hyderabad-based drug maker Natco Pharma Ltd on Wednesday announced that it has launched a generic version of pomalidomide 1 mg, 2 mg, and 4 mg capsules in India. Pomalidomide is anti-angiogenic and also acts as an immunomodulator. The drug is sold by American biotechnology company   Celgene Inc.,in the USA, under the brand name Pomalyst. “Pomalidomide is a thalidomide analogue indicated, in combination with dexamethasone, for Read more…

By Team MedsDelta, ago
Hepatitis Medicine India

BioGeneric Epclusa (sofosbuvir/velpatasvir) hepatitis C drug Velpanat in India by Natco Pharma

Velpatasvir Sofosbuvir Tablets Natco Pharma India NatcoPharma Limited has launched a hepatitis C drug – a fixed dose combination of sofosbuvir (400 mg) & velpatasvir (100 mg) – under the brand name of Velpanat in India. Velpanat is the generic version of Epclusa, manufactured by Gilead Sciences Inc globally Epclusa is the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C virus (HCV) infection. Epclusa is a Read more…

By Team MedsDelta, ago